News3 mins ago
PathomIQ’s AI-powered tool shows promise in assessing risk for metastasis in non-metastatic castration-resistant prostate cancer (nmCRPC)
CUPERTINO, Calif., June 6, 2023 /PRNewswire/ — New data released today at the American Society of Clinical Oncology (ASCO) Annual Meeting highlighted the application of PathomIQ...
